Boston Scientific Corp (BSX)

[conix]

Boston Scientific EPS beats by $0.06, beats on revenue

Apr. 28, 2021

By: Gaurav Batavia, SA News Editor

Boston Scientific (NYSE:BSX): Q1 Non-GAAP EPS of $0.37 beats by $0.06; GAAP EPS of $0.23 beats by $0.12.

Revenue of $2.75B (+8.3% Y/Y) beats by $130M.

FY21 Guidance: The company now estimates earnings on a GAAP basis in a range of $0.81 to $0.88 per share and estimates adjusted earnings, excluding certain charges (credits), of $1.53 to $1.60 per share vs. $1.54 consensus. The company now estimates net sales growth for the full year 2021, versus the prior year period, to be in a range of approximately 16 to 19 percent on a reported basis, and approximately 15 to 18 percent on an organic basis.

Q2 Guidance: The company estimates earnings on a GAAP basis in a range of $0.16 to $0.18 per share and adjusted earnings, excluding certain charges (credits), of $0.36 to $0.38 per share vs. $0.35 consensus. The company estimates net sales growth for the second quarter of 2021, versus the prior year period, to be in a range of approximately 46 to 50 percent on a reported basis and approximately 44 to 48 percent on an organic basis.
Shares +2.2% PM.